| Literature DB >> 24980602 |
Gerard J Fitzmaurice1, Billy McWilliams2, Lars Nölke3, J Mark Redmond3, Jonathan G McGuinness3, Mark E O'Donnell4.
Abstract
Cardiac surgical patients often have associated comorbidities that can impede normal wound healing; however, statin therapy has the potential to improve this process through augmentation of the normal inflammatory response. Outcomes included a 30% earlier rate of wound epithelialization and an 80% greater wound-breaking strength combined with faster wound healing rates (13.0 days vs 18.7 days, p<0.0001). Inhibition of farnesyl pyrophosphate may hold a key role in the mediation of such advantageous effects. This systematic review suggests that there is sufficient evidence to warrant completion of a human trial to assess the effects of statins on wound healing.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24980602 DOI: 10.1016/j.athoracsur.2014.02.089
Source DB: PubMed Journal: Ann Thorac Surg ISSN: 0003-4975 Impact factor: 4.330